These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34463045)

  • 21. Effects of dorzolamide hydrochloride on ocular tissues.
    Inoue J; Oka M; Aoyama Y; Kobayashi S; Ueno S; Hada N; Takeda T; Takehana M
    J Ocul Pharmacol Ther; 2004 Feb; 20(1):1-13. PubMed ID: 15006154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of retinal hemodynamics with the Canon laser blood flowmeter after a single dose of 2% dorzolamide hydrochloride eyedrops.
    Faingold D; Hudson C; Flanagan J; Guan K; Rawji M; Buys YM; Trope GE
    Can J Ophthalmol; 2004 Aug; 39(5):506-10. PubMed ID: 15491034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
    Maren TH; Bar-Ilan A; Conroy CW; Brechue WF
    Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of topical dorzolamide on optic nerve head blood flow.
    Pillunat LE; Böhm AG; Köller AU; Schmidt KG; Klemm M; Richard G
    Graefes Arch Clin Exp Ophthalmol; 1999 Jun; 237(6):495-500. PubMed ID: 10379611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ocular hemodynamics and visual field in glaucoma treated with dorzolamide].
    Bernd AS; Pillunat LE; Böhm AG; Schmidt KG; Richard G
    Ophthalmologe; 2001 May; 98(5):451-5. PubMed ID: 11402826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
    Balfour JA; Wilde MI
    Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
    Dwivedi R; Tiroumal S
    Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TOPICAL DORZOLAMIDE FOR CYSTOID MACULAR EDEMA IN BIETTI CRYSTALLINE RETINAL DYSTROPHY.
    Khojasteh H; Roohipoor R; Riazi-Esfahani H; Ghasempour M
    Retin Cases Brief Rep; 2021 May; 15(3):306-309. PubMed ID: 30028788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of topical dorzolamide on rabbit central corneal thickness.
    Almeida GC; Faria e Souza SJ
    Braz J Med Biol Res; 2006 Feb; 39(2):277-81. PubMed ID: 16470316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits.
    Warsi MH; Anwar M; Garg V; Jain GK; Talegaonkar S; Ahmad FJ; Khar RK
    Colloids Surf B Biointerfaces; 2014 Oct; 122():423-431. PubMed ID: 25159319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ocular pulse amplitude, intraocular pressure and beta blocker/carbonic anhydrase inhibition in combined therapy of primary open-angle glaucoma].
    Schmidt KG; von Rückmann A; Becker R; Pillunat LE
    Klin Monbl Augenheilkd; 1999 Dec; 215(6):361-6. PubMed ID: 10637801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STELLATE NONHEREDITARY IDIOPATHIC FOVEOMACULAR RETINOSCHISIS: RESPONSE TO TOPICAL DORZOLAMIDE THERAPY.
    Ajlan RS; Hammamji KS
    Retin Cases Brief Rep; 2019; 13(4):364-366. PubMed ID: 28557864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dilatation of Retinal Arterioles Induced by Topical Dorzolamide for One Week Is Impaired in Patients with Type 1 Diabetes and Mild Retinopathy.
    Tilma KK; Bek T
    Ophthalmologica; 2020; 243(3):236-242. PubMed ID: 31805549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of topical dorzolamide on IOP after phacoemulsification with different types of ophthalmic viscosurgical devices.
    Koçak-Altintas AG; Anayol MA; Cakmak HB; Simsek S
    Eur J Ophthalmol; 2007; 17(1):38-44. PubMed ID: 17294381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide.
    Larsson LI; Alm A
    Arch Ophthalmol; 1998 Jan; 116(1):19-24. PubMed ID: 9445204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of dorzolamide on corneal endothelium.
    Inoue K; Okugawa K; Oshika T; Amano S
    Jpn J Ophthalmol; 2003; 47(2):129-33. PubMed ID: 12738544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.
    Bušić M; Bjeloš M; Bosnar D; Ramić S; Bušić I
    Doc Ophthalmol; 2016 Feb; 132(1):67-73. PubMed ID: 26803827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erythema multiforme after use of topical dorzolamide.
    Munshi V; Ahluwalia H
    J Ocul Pharmacol Ther; 2008 Feb; 24(1):91-3. PubMed ID: 18370879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of twice daily application of 2% dorzolamide on intraocular pressure in normal cats.
    Rainbow ME; Dziezyc J
    Vet Ophthalmol; 2003 Jun; 6(2):147-50. PubMed ID: 12753617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dorzolamide-timolol combination versus concomitant administration of its components.
    Odberg T
    Ophthalmology; 1999 Jun; 106(6):1044-5. PubMed ID: 10366067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.